GRIGGS STEPHEN P
Known title: Chief Executive OfficerCIK: 0001275762
GRIGGS STEPHEN P's purchase track record
GRIGGS STEPHEN P has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/3/2022 | AHCO | $500K | +21.2% | +18.2% | -9.1% |
| 11/30/2021 | AHCO | $971K | -18.9% | -8.3% | -9.5% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| AHCO | ▲ Buy | Option Exercise | 559,071 | $2.4M | 5/8/2023 | View on chart |
| AHCO | ▼ Sell | Tax Withholding | 345,219 | $4.1M | 5/8/2023 | View on chart |
| AHCO | ▲ Buy | Grant | 77,938 | $0 | 3/9/2023 | View on chart |
| AHCO | ▲ Buy | Open Market | 32,342 | $500K | 3/3/2022 | View on chart |
| AHCO | ▲ Buy | Grant | 7,650 | $0 | 2/16/2022 | View on chart |
| AHCO | ▲ Buy | Grant | 81,617 | $0 | 2/1/2022 | View on chart |
| AHCO | ▲ Buy | Open Market | 50,000 | $971K | 11/30/2021 | View on chart |
| AHCO | ▲ Buy | Grant | 13,258 | $0 | 10/11/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
AdaptHealth (AHCO) flagged in Yahoo's cautionary stock list
A recent Yahoo article placed AHCO among three stocks that Wall Street should think twice about. The piece suggests investors may need to re‑evaluate expectations for the company. The stock is currently near its long‑term support level of $5.70 and shows a moderate RSI, which aligns with the cautious tone of the article.
AdaptHealth (AHCO) flagged in Yahoo's cautionary stock list. A recent Yahoo article placed AHCO among three stocks that Wall Street should think twice about. The piece suggests investors may need to re‑evaluate expectations for the company. The stock is currently near its long‑term support level of $5.70 and shows a moderate RSI, which aligns with the cautious tone of the article.